0 CHECKOUT

Royal DSM N.V. - SWOT, Strategy and Corporate Finance Report

  • ID: 2259262
  • January 2013
  • 52 pages
  • MarketLine

Royal DSM N.V. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.

Features:

- Detailed information on Royal DSM N.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Royal DSM N.V. in the form of a SWOT analysis
- An in-depth view of the business model of Royal DSM N.V. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Royal DSM N.V.
- Intelligence on Royal DSM N.V.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Royal DSM N.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present READ MORE >

Note: Product cover images may vary from those shown

Company Snapshot
Royal DSM N.V.: Company Overview
Royal DSM N.V.: Overview and Key Facts

Royal DSM N.V.: Overview

Royal DSM N.V.: Key Facts
Royal DSM N.V.: Key Employees
Royal DSM N.V.: Key Employee Biographies
Royal DSM N.V.: Major Products and Services
Royal DSM N.V.: Company History
Royal DSM N.V.: Management Statement
Royal DSM N.V.: Locations and Subsidiaries
Royal DSM N.V.: Key Competitors
Royal DSM N.V.: Company Analysis
Royal DSM N.V.: Business Description
Royal DSM N.V.: SWOT Analysis

Royal DSM N.V.: SWOT Overview

Royal DSM N.V.: Strengths

Royal DSM N.V.: Weaknesses

Royal DSM N.V.: Opportunities

Royal DSM N.V.: Threats
Royal DSM N.V.: Corporate Financial Deals Activity
Royal DSM N.V.: Financial Deals Overview
Royal DSM N.V.: Targets and Partners
Royal DSM N.V.: Top Deals 2008 - 2012YTD-
Royal DSM N.V.: Advisors

Royal DSM N.V.: Top Legal Advisors

Royal DSM N.V.: Top Financial Advisors
Royal DSM N.V.: Mergers and Acquisitions
Royal DSM N.V.: Corporate Venturing
Royal DSM N.V.: Partnership
Royal DSM N.V.: Divestments
Royal DSM N.V.: Private Equity and Ownership
Royal DSM N.V.: Recent Developments
Royal DSM N.V.: News and Events Summary
Royal DSM N.V.: Business Expansion
Royal DSM N.V.: Contracts
Royal DSM N.V.: Corporate Governance
Royal DSM N.V.: Financial Deals
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Royal DSM N.V.: Key Facts
Table 2: Royal DSM N.V.: Key Employees
Table 4: Royal DSM N.V.: Key Competitors
Table 5: Royal DSM N.V.: Deal Activity by Deal Type - Volume (TTM-)
Table 6: Royal DSM N.V.: M&A Activity by Geography (TTM-)
Table 7: Royal DSM N.V.: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Table 8: Royal DSM N.V.: M&A Average Deal Size - Value (US$m)
Table 9: Royal DSM N.V.: Targets and Partners
Table 10: Royal DSM N.V.: Top Deals 2008 - 2012YTD-
Table 11: Royal DSM N.V.: Legal Advisor Ranking by Value (US$m)
Table 12: Royal DSM N.V.: Financial Advisor Ranking by Value (US$m)
Table 13: Royal DSM N.V.: M&A Volume and Value Trend (2008 - YTD-2012)
Table 14: Royal DSM N.V.: M&A Activity by Geography (2008 - YTD-2012)
Table 15: Royal DSM N.V.: Corporate Venturing Volume and Value Trend (2008 - YTD-2012)
Table 16: Royal DSM N.V.: Corporate Venturing by Geography (2008 - YTD-2012)
Table 17: Royal DSM N.V.: Partnership Volume and Value Trend (2008 - YTD-2012)
Table 18: Royal DSM N.V.: Partnership Trend by Deal Type (2008 - YTD-2012)
Table 19: Royal DSM N.V.: Divestments Volume and Value Trend (2008 - YTD-2012)
Table 20: Royal DSM N.V.: Divestments by Geography (2008 - YTD-2012)
Table 21: Royal DSM N.V.: Private Equity and Ownership Volume and Value Trend (2008 - YTD-2012)
Table 22: Royal DSM N.V.: Private Equity and Ownership Volume by Deal Type (2008 - YTD-2012)
Table 23: Royal DSM N.V.: News and Events Summary
Table 24: Royal DSM N.V.: Business Expansion
Table 25: Royal DSM N.V.: Contracts
Table 26: Royal DSM N.V.: Corporate Governance
Table 27: Royal DSM N.V.: Financial Deals

List of Figures

Figure 1: Royal DSM N.V.: Deal Activity by Deal Type - Volume (TTM-)
Figure 2: Royal DSM N.V.: M&A Activity by Geography (TTM-)
Figure 3: Royal DSM N.V.: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Figure 4: Royal DSM N.V.: M&A Average Deal Size - Value (US$m)
Figure 5: Royal DSM N.V.: M&A Volume and Value Trend (2008 - YTD-2012)
Figure 6: Royal DSM N.V.: M&A Activity by Geography (2008 - YTD-2012)
Figure 7: Royal DSM N.V.: Corporate Venturing Volume and Value Trend (2008 - YTD-2012)
Figure 8: Royal DSM N.V.: Corporate Venturing by Geography (2008 - YTD-2012)
Figure 9: Royal DSM N.V.: Partnership Volume and Value Trend (2008 - YTD-2012)
Figure 10: Royal DSM N.V.: Partnership Trend by Deal Type (2008 - YTD-2012)
Figure 11: Royal DSM N.V.: Divestments Volume and Value Trend (2008 - YTD-2012)
Figure 12: Royal DSM N.V.: Divestments by Geography (2008 - YTD-2012)
Figure 13: Royal DSM N.V.: Private Equity and Ownership Volume and Value Trend (2008 - YTD-2012)
Figure 14: Royal DSM N.V.: Private Equity and Ownership Volume by Deal Type (2008 - YTD-2012)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.